Physician profile
Mark Malkin
NPI 1851344584
$2,062.44
in general payments reported to CMS, 2019-2025
8 companies · $748 in 2025
The $748 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2021: $162 · 2022: $160 · 2023: $334 · 2024: $363 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $1,324.83 | 2019-2025 | Optune Gio, Optune |
| Springworks Therapeutics, INC. | $245.52 | 2025 | Gomekli, Ogsiveo |
| Monteris Medical Corporation | $172.47 | 2022-2025 | Neuroblate |
| Ucb, INC. | $109.33 | 2025 | Nayzilam |
| Neurelis, INC. | $88.93 | 2024 | Valtoco |
| Gt Medical Technologies, INC | $60.68 | 2023 | Gammatile |
| Medexus Pharma, INC. | $60.68 | 2023 | Gleolan |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Malkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.